Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Immunogenicity and Safety of Hexaxim in Indian Infants
NCT01948193Phase 3Completed
- Sponsor
- Sanofi
- Start
- Feb 2014
- Primary completion
- Dec 2014
- Modality
- Recombinant Proteins and Enzymes, Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of hexaxim in diphtheria, Tetanus, pertussis, hepatitis B (HBV), poliomyelitis, sponsored by Sanofi. Started Feb 2014; status: completed.
02
Drugs
hexaxim
03
Conditions
diphtheriaTetanuspertussishepatitis B (HBV)poliomyelitis
Beyond the preview
Go deeper on NCT01948193.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01948193.